Lam Research (LRCX)
(Delayed Data from NSDQ)
$814.09 USD
+16.71 (2.10%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $817.00 +2.91 (0.36%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$814.09 USD
+16.71 (2.10%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $817.00 +2.91 (0.36%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth C Momentum C VGM
Zacks News
Lam Research (LRCX) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Lam Research (LRCX) closed the most recent trading day at $152.75, moving -0.71% from the previous trading session.
Zacks Value Trader Highlights: NVIDIA, Lam Research, Micron, Intel, Applied Materials and Applied Micro Devices
by Zacks Equity Research
Zacks Value Trader Highlights: NVIDIA, Lam Research, Micron, Intel, Applied Materials and Applied Micro Devices
There's No Such Thing as Free Money
by David Borun
The collapse of Optionseller.com is a stark reminder of how risky some strategies can be
The Semiconductors After the Sell Off: Are they Value Stocks or Traps?
by Tracey Ryniec
Many of the semiconductor stocks have sold off in the recent market weakness and are now trading with single digit P/Es. Should value investors be taking a look?
Lam Research (LRCX) Stock Moves -0.2%: What You Should Know
by Zacks Equity Research
In the latest trading session, Lam Research (LRCX) closed at $143.45, marking a -0.2% move from the previous day.
Bear of the Day: Western Digital (WDC)
by Benjamin Rains
It has been a rough year for Western Digital (WDC) and things look like they could keep getting worse.
Bear of the Day: Ultra Clean (UCTT)
by Kevin Cook
As the Semi Cycle goes full melt-down with NVDA, this specialty "cleaner" gave fair warning in August
Why Is Lam Research (LRCX) Down 3% Since Last Earnings Report?
by Zacks Equity Research
Lam Research (LRCX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Lam Research (LRCX) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Lam Research (LRCX) closed at $142.74, marking a -0.84% move from the previous day.
Stocks End Higher After an Eventful Week
by David Borun
Mid-term elections and a Fed meeting highlight a week of broad gains
Lam Research (LRCX) Stock Moves -0.01%: What You Should Know
by Zacks Equity Research
Lam Research (LRCX) closed the most recent trading day at $151.68, moving -0.01% from the previous trading session.
A Strong Week in the Markets to Finish off a Volatile October
by David Borun
After weeks of selling pressure, US equities stage a comeback
Lam Research (LRCX) Stock Moves -0.23%: What You Should Know
by Zacks Equity Research
Lam Research (LRCX) closed the most recent trading day at $151.51, moving -0.23% from the previous trading session.
Lam Research (LRCX) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Lam Research (LRCX) closed at $144.27, marking a -0.64% move from the previous day.
The Zacks Analyst Blog Highlights: AstraZeneca, salesforce, Mastercard, Lam Research and Koninklijke
by Zacks Equity Research
The Zacks Analyst Blog Highlights: AstraZeneca, salesforce, Mastercard, Lam Research and Koninklijke
Top Analyst Reports for AstraZeneca, Salesforce & Mastercard
by Mark Vickery
Today's Research Daily features new research reports on 12 major stocks, including AstraZeneca (AZN), salesforce.com (CRM) and Mastercard (MA)
Lam Research (LRCX) Beats on Q1 Earnings, Q2 Outlook Positive
by Zacks Equity Research
Lam Research's (LRCX) first-quarter fiscal 2019 results benefit from improved performance by the memory segment, which accounted for 77% of total revenues.
Lam Research (LRCX) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Lam Research (LRCX) delivered earnings and revenue surprises of 4.67% and 1.16%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
This Week's Most Spectacular Earnings Charts
by Tracey Ryniec
It doesn't get much better than these five big cap companies with their outstanding earnings surprise records and great earnings charts.
Why Lam Research (LRCX) Could Beat Earnings Estimates Again
by Zacks Equity Research
Lam Research (LRCX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Lam Research (LRCX) Might Surprise This Earnings Season
by Zacks Equity Research
Lam Research (LRCX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Friday Bounce Ends a Volatile Week for Stocks
by David Borun
Interest rates fears fuel the biggest weekly decline in 7 months
Can Strong Memory Aid Lam Research (LRCX) in Q1 Earnings?
by Zacks Equity Research
Lam Research's (LRCX) fiscal first-quarter results are likely to benefit from strong memory market and shipments. However, volatility in the PC market remains a concern.
Lam Research (LRCX) Stock Moves -1.55%: What You Should Know
by Zacks Equity Research
Lam Research (LRCX) closed at $137.62 in the latest trading session, marking a -1.55% move from the prior day.
Lam Research (LRCX) Q1 Earnings Preview: What's Shaping Up?
by Zacks Equity Research
Lam Research (LRCX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.